Oilfield services company Schlumberger Limited’s (NYSE: SLB) restructuring efforts apparently backfired as it missed the analyst's estimates in the last…
Fate Therapeutics, Inc. (NASDAQ: FATE), a clinical-stage biopharma company, has been drawing the market's attention after reporting positive results from…